Pfizer and BioNTech lose UK court appeal over Covid-19 jab
Moderna has accused Pfizer and BioNTech of violating its intellectual property rights with regard to mRNA technology.
LONDON - US pharmaceutical giant Pfizer and German firm BioNTech lost on Aug 1 a court appeal in the latest step of
a multi-million pound battle against US rival Moderna over the Covid-19 vaccine.
The Appeals Court in London upheld an earlier UK court decision in the long-running battle between the global pharma firms.
It found that one of the European patents held by Moderna was invalid, but that a second one had been broken by Pfizer and its German partner BioNTech.
'The judge made no error of law or principle' in the ruling handed down in July 2024, the Appeal Court judges wrote Friday, dismissing the appeal brought by the two companies.
Pfizer quickly said it will appeal the Aug 1 ruling to Britain's Supreme Court.
'Today's UK Court of Appeal's decision does not change our unwavering stance that this patent is invalid,' Pfizer said in a statement.
'This decision has no immediate impact on Pfizer and BioNTech.'
Pfizer and BioNTech had argued that both the patents cited by Moderna were invalid, and neither had been infringed.
The Aug 1 decision could have wide implications for other cases involving the huge pharma companies in the United States, Germany, Belgium, the Netherlands and Ireland.
Moderna said in a statement it was pleased with the Aug 1 ruling and would 'continue to pursue and enforce its patent rights globally to protect its innovative mRNA technology'.
A UK court was told in 2024 the firms had spent £19 million (S$32 million) fighting their legal battles.
In 2020, Pfizer and BioNTech's vaccine became the first ever mRNA vaccine approved for widespread use, and was swiftly deployed to combat the Covid-19 pandemic.
Scientists believe mRNA vaccines, which provoke an immune response by delivering genetic molecules containing the code for key parts of a pathogen into human cells, could be a game-changer against many diseases.
Traditional vaccines contain some form of the dead or inactivated target virus.
Since the virus need not be grown in the lab, mRNA vaccines can in theory be developed at scale more quickly than traditional vaccines.
In March, a German court in Duesseldorf also found Pfizer and BioNTech had violated a Moderna patent filed between 2010 to 2016 to make their vaccines.
It ordered they must provide estimates of how much they had profited from breaking the patent as well as provide 'appropriate compensation'. AFP
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Straits Times
27 minutes ago
- Straits Times
Germany halts military exports that could be used in Gaza, says German Chancellor Merz
Sign up now: Get ST's newsletters delivered to your inbox German Chancellor Friedrich Merz said Germany's top priorities are the release of hostages and negotiations for a ceasefire. BERLIN - The German government will not approve any exports of military equipment that could be used in the Gaza Strip until further notice, Chancellor Friedrich Merz said on Aug 8 in response to Israel's plan to expand its military operations there. Israel's political-security Cabinet approved a plan early on Aug 8 to take control of Gaza City , a move expanding its military operations despite intensifying criticism at home and abroad over the devastating, almost two-year-old war. Mr Merz said it was Israel's right to disarm Hamas and to seek the release of the Israeli hostages. 'The German government believes that the even tougher military action in the Gaza Strip decided upon by the Israeli Cabinet last night makes it increasingly difficult to see how these goals can be achieved,' he said in a statement. 'Under these circumstances, the German government will not approve any exports of military equipment that could be used in the Gaza Strip until further notice.' Far-right allies in Prime Minister Benjamin Netanyahu's coalition have been pushing for a total takeover of Gaza as part of his vow to eradicate Hamas militants, though the military has warned this could jeopardise the lives of remaining hostages. The release of the hostages and negotiations for a ceasefire are Germany's top priorities, Mr Merz said, expressing deep concern over the suffering of civilians in the Gaza strip. Top stories Swipe. Select. Stay informed. Singapore PM Wong calls on S'poreans to band together for nation to remain exceptional in National Day message Singapore Four foreign leaders to attend NDP 2025 at the Padang Singapore NDP 2025: No ticket, no problem – here are some spots to soak up National Day vibes Business Singapore's digital banks trim deposit rates, mirroring moves by incumbent players Singapore Non-invasive depression treatment TMS has helped engineer get his life back Life S'pore's nightlife isn't dead yet: A nightlife reporter's 6 favourite places to drink Singapore Ex-lawyer convicted of cheating, forgery charges involving more than $8 million Singapore Chief Justice names law graduate who wanted anonymity after being denied Bar admission Germany's Parliament said in June that export licences for military equipment to Israel worth €485 million (S$725 million) were granted between Oct 7, 2023 and May 13, 2025. REUTERS
Straits Times
28 minutes ago
- Straits Times
India pauses plans to buy US arms after Trump's tariffs
Sign up now: Get ST's newsletters delivered to your inbox New Delhi has put on hold its plans to procure new US weapons and aircraft. NEW DELHI - New Delhi has put on hold its plans to procure new US weapons and aircraft, according to three Indian officials familiar with the matter, in India's first concrete sign of discontent after tariffs imposed on its exports by President Donald Trump dragged ties to their lowest level in decades. India had been planning to send Defence Minister Rajnath Singh to Washington in the coming weeks for an announcement on some of the purchases, but that trip has been cancelled, two of the people said. Mr Trump on Aug 6 imposed an additional 25 per cent tariff on Indian goods as punishment for Delhi's purchases of Russian oil, which he said meant the country was funding Russia's invasion of Ukraine. That raised the total duty on Indian exports to 50 per cent – among the highest of any US trading partner. The president has a history of rapidly reversing himself on tariffs and India has said it remains actively engaged in discussions with Washington. One of the people said the defence purchases could go ahead once India had clarity on tariffs and the direction of bilateral ties, but 'just not as soon as they were expected to'. Written instructions had not been given to pause the purchases, another official said, indicating that Delhi had the option to quickly reverse course, though there was 'no forward movement at least for now'. India's defence ministry and the Pentagon did not respond to Reuters' questions. Delhi, which has forged a close partnership with America in recent years, has said it is being unfairly targeted and that Washington and its European allies continue to trade with Moscow when it is in their interest. Reuters is reporting for the first time that discussions on India's purchases of Stryker combat vehicles made by General Dynamics Land Systems and Javelin anti-tank missiles developed by Raytheon and Lockheed Martin have been paused due to the tariffs. Mr Trump and Indian Prime Minister Narendra Modi had in February announced plans to pursue procurement and joint production of those items. Mr Singh had also been planning to announce the purchase of six Boeing P8I reconnaissance aircraft and support systems for the Indian Navy during his now-cancelled trip, two of the people said. Talks over procuring the aircraft in a proposed US$3.6 billion (S$4.6 billion) deal were at an advanced stage, according to the officials. Boeing, Lockheed Martin and General Dynamics referred queries to the Indian and US governments. Raytheon did not return a request for comment. Russian relations India's deepening security relationship with the US, which is fuelled by their shared strategic rivalry with China, was heralded by many US analysts as one of the key areas of foreign-policy progress in the first Trump administration. Delhi is the world's second-largest arms importer and Russia has traditionally been its top supplier. India has in recent years however, shifted to importing from Western powers like France, Israel and the US, according to the Stockholm International Peace Research Institute think-tank. The shift in suppliers was driven partly by constraints on Russia's ability to export arms, which it is utilising heavily in its invasion of Ukraine. Some Russian weapons have also performed poorly in the battlefield, according to Western analysts. The broader US-India defence partnership, which includes intelligence sharing and joint military exercises, continues without hiccups, one of the Indian officials said. India also remains open to scaling back on oil imports from Russia and is open to making deals elsewhere, including the US, if it can get similar prices, according to two other Indian sources. Mr Trump's threats and rising anti-US nationalism in India have 'made it politically difficult for Modi to make the shift from Russia to the US', one of the people said. Nonetheless, discounts on the landing cost of Russian oil have shrunk to the lowest since 2022. India's petroleum ministry did not immediately respond to a request for comment. While the rupture in US-India ties was abrupt, there have been strains in the relationship. Delhi has repeatedly rebutted Mr Trump's claim that the US brokered a ceasefire between India and Pakistan after four days of fighting between the nuclear-armed neighbours in May. Mr Trump also hosted Pakistan's army chief at the White House in the weeks following the conflict. In recent months, Moscow has been actively pitching Delhi on buying new defence technologies like its S-500 surface-to-air missile system, according to one of the Indian officials, as well as a Russian source familiar with the talks. India currently does not see a need for new arms purchases from Moscow, two Indian officials said. But Delhi is unlikely to wean itself off Russian weapons entirely as the decades-long partnership between the two powers means Indian military systems will continue to require Moscow's support, one of the officials said. The Russian embassy in Delhi did not immediately respond to a request for comment. REUTERS
Business Times
28 minutes ago
- Business Times
HSBC takes extra space in Canary Wharf due to HQ squeeze
[LONDON] HSBC has signed a lease to take extra space in Canary Wharf before shifting its global headquarters away from the East London financial district, according to a company memo seen by Reuters, owing to a shortage of space at its planned new base in the central City of London area. The banking giant has signed a contract to take a number of floors at 40 Bank Street, not far from the 45-floor skyscraper it currently occupies in Canary Wharf, the memo said. Canary Wharf Group, the district's landlord, later confirmed that HSBC had signed a 15-year lease for 210,000 square feet at the Bank Street building. The lender is moving its headquarters in London to a building roughly half the size near St Paul's Cathedral but had realised it would lack sufficient space and had been assessing other options, Reuters has reported. HSBC will move staff into the new Canary Wharf office from early 2027, the company said in its memo, adding that it would continue to operate from multiple sites across London to access clients across the city. Bloomberg previously reported that HSBC was in discussions about leasing the space at 40 Bank Street. HSBC's decision will provide a boost to Canary Wharf, where office values have declined since the Covid-19 pandemic and several planned departures including HSBC and law firm Clifford Chance. Several companies have signed up for space in the district in recent months as return-to-office mandates have contributed to a shortage of quality space, particularly in the central City of London. Spanish bank BBVA has signed a lease to take 250,000 sq ft in Canary Wharf, Canary Wharf Group said this week, while fintech company Zopa is moving its headquarters to the district. REUTERS
